CIRM provides funding across five key areas: Infrastructure, Education, Discovery Research, Translational Research, and Clinical Research. By supporting projects at every stage of development, from initial discovery to clinical trials, CIRM drives progress in regenerative medicine and accelerates innovative therapies to patients.
Check out our portfolio of awards below. Click here to see a list of People We’ve Funded. Click here to see a list of our Funded Institutions.
All CIRM Grants
Search Filters »
| Institution |
Researcher name |
Grant Type |
Grant Title |
Award Value |
| ViaCyte, Inc. |
Allan Robins |
Disease Team Research I |
Cell Therapy for Diabetes |
$0 |
| Cedars-Sinai Medical Center |
Eduardo Marbán |
Disease Team Research I |
Autologous cardiac-derived cells for advanced ischemic cardiomyopathy |
$5,560,232 |
| University of California, San Francisco |
Dr. Mitchel S Berger |
Disease Team Research I |
Stem Cell-Mediated Oncocidal Gene Therapy of Glioblastoma (GBM) |
$6,214,914 |
| City of Hope, Beckman Research Institute |
Prof. Karen S Aboody M.D. |
Disease Team Research I |
Stem Cell-mediated Therapy for High-grade Glioma: Toward Phase I-II Clinical Trials |
$17,890,623 |
| Stanford University |
Dr. Alfred T Lane |
Disease Team Research I |
iPS Cell-Based Treatment of Dominant Dystrophic Epidermolysis Bullosa |
$11,039,208 |
| Stanford University |
Professor Irving L Weissman MD |
Disease Team Research I |
Development of Therapeutic Antibodies Targeting Human Acute Myeloid Leukemia Stem Cells |
$18,759,276 |
| University of California, Los Angeles |
Dr. Dennis J Slamon |
Disease Team Research I |
Therapeutic Opportunities To Target Tumor Initiating Cells in Solid Tumors |
$19,979,660 |
| City of Hope, Beckman Research Institute |
Prof. John A. Zaia |
Disease Team Research I |
ZINC FINGER NUCLEASE-BASED STEM CELL THERAPY FOR AIDS |
$14,536,969 |
| University of Southern California |
Mark Salman Humayun |
Disease Team Research I |
Stem cell based treatment strategy for Age-related Macular Degeneration (AMD) |
$18,904,916 |
| University of California, San Diego |
Dr. Dennis A Carson |
Disease Team Research I |
Development of Highly Active Anti-Leukemia Stem Cell Therapy (HALT) |
$19,999,826 |
| University of California, San Diego |
Dr. Gene Wei-Ming Yeo |
Basic Biology I |
RNA Binding Protein-mediated Post-transcriptional Networks Regulating HPSC Pluripotency |
$1,308,901 |
| University of California, San Diego |
Karl H. Willert |
Basic Biology I |
WNT signaling and the control of cell fate decisions in human pluripotent stem cells. |
$1,329,298 |
| University of California, Davis |
Dr. Min Zhao |
Basic Biology I |
Directing migration of human stem cells with electric fields |
$816,228 |
| University of California, Los Angeles |
Dr. Michael A. Teitell |
Basic Biology I |
Mitochondrial Metabolism in hESC and hiPSC Differentiation, Reprogramming, and Cancer |
$1,323,029 |
| University of Southern California |
Dr. Martin Pera |
Basic Biology I |
The stem cell microenvironment in the maintenance of pluripotency and reprogramming |
$1,325,723 |
| Stanford University |
Dr. Julien Sage |
Basic Biology I |
The retinoblastoma (RB) gene family in cellular reprogramming |
$1,357,085 |
| Stanford University |
Dr. Susan K McConnell |
Basic Biology I |
Identification and characterization of human ES-derived DA neuronal subtypes |
$1,404,853 |
| University of California, Los Angeles |
Bennett G Novitch |
Basic Biology I |
Molecular Characterization of hESC and hIPSC-Derived Spinal Motor Neurons |
$1,228,278 |
| University of California, Los Angeles |
Dr. Robb Maclellan Dr. |
Basic Biology I |
Human Cardiovascular Progenitors, their Niches and Control of Self-renewal and Cell Fate |
$917,667 |
| University of Southern California |
Dr. Wange Lu |
Basic Biology I |
Defining the molecular mechanisms of somatic cell reprogramming |
$1,365,580 |
| Stanford University |
Professor Helen M. Blau PhD |
Basic Biology I |
Molecular Mechanisms of Reprogramming towards Pluripotency |
$1,408,332 |
| University of California, Los Angeles |
Dr. Luisa Iruela-Arispe |
Basic Biology I |
Molecular Characterization and Functional Exploration of Hemogenic Endothelium |
$1,371,477 |
| Lundquist Institute for Biomedical Innovation at Harbor – UCLA Medical Center |
Dr. Virender K. Rehan M.D. |
Research Training Grant |
Stem Cell Training Program at the Lundquist Institute |
$5,349,109 |
| University of California, Irvine |
Dr. Peter J Donovan |
Research Training Grant |
CIRM Scholars Comprehensive Research Training Program |
$5,373,742 |
| University of California, Santa Barbara |
Dr. Dennis O. Clegg Dr. |
Research Training Grant |
CIRM Training Program in Stem Cell Biology and Engineering |
$2,298,239 |
| Sanford Burnham Prebys Medical Discovery Institute |
Dr. Evan Y. Snyder |
Research Training Grant |
A Multidisciplinary Stem Cell Training Program at Sanford Burnham Prebys Institute, A Critical Component of the La Jolla Mesa Educational Network |
$5,289,413 |
| University of California, San Francisco |
Dr. Robert Blelloch MD, PHD. |
Research Training Grant |
Scholars Research Training Program in Regenerative Medicine, Gene Therapy, and Stem Cell Research |
$5,373,742 |
| Scripps Research Institute |
Peter G. Schultz |
Research Training Grant |
Training Scholars in Regenerative Medicine and Stem Cell Research |
$5,304,759 |
| University of California, San Diego |
Professor Alysson R Muotri |
Research Training Grant |
Interdisciplinary Stem Cell Training Grant at UCSD III |
$5,366,188 |
| Children’s Hospital of Los Angeles |
Dr Ching-Ling Lien Ph.D. |
Research Training Grant |
CIRM Training Program for Stem Cell and Regenerative Medicine Research |
$5,373,242 |
| University of California, Davis |
Dr Jan A Nolta |
Research Training Grant |
CIRM Cell and Gene Therapy Training Program 2.0 |
$5,013,550 |
| University of California, Berkeley |
Dirk Hockemeyer |
Research Training Grant |
Training the Next Generation of Biologists and Engineers for Regenerative Medicine |
$5,327,980 |
| Stanford University |
Tushar Desai |
Research Training Grant |
CIRM Scholar Training Program |
$5,347,815 |
| City of Hope, Beckman Research Institute |
Dr. Michael E. Barish Ph, D. |
Research Training Grant |
Research Training Program in Stem Cell Biology and Regenerative Medicine |
$5,234,731 |
| Gladstone Institutes, J. David |
Dr. Bruce R. Conklin |
Research Training Grant |
CIRM Regenerative Medicine Research Training Program |
$5,373,742 |
| University of California, Santa Cruz |
Dr. Camilla Forsberg |
Research Training Grant |
CIRM Training Program in Systems Biology of Stem Cells |
$5,278,566 |
| University of Southern California |
Dr. Francesca Mariani |
Research Training Grant |
Training Program Bridging Stem Cell Research with Clinical Applications in Regenerative Medicine |
$5,373,742 |
| University of California, Los Angeles |
William Lowry |
Research Training Grant |
UCLA Training Program in Stem Cell Biology |
$5,373,742 |
| The Regents of the University of California on behalf of its Riverside Campus |
Dr. Prue Talbot |
Research Training Grant |
TRANSCEND – Training Program to Advance Interdisciplinary Stem Cell Research, Education, and Workforce Diversity |
$5,344,306 |
| Cedars-Sinai Medical Center |
Cedars-Sinai Medical Center Wafa Tawackoli |
Research Training Grant |
CIRM Training Program in Translational Regenerative Medicine |
$5,373,075 |
| University of California, San Diego |
Dr. Steven F Dowdy |
Discovery Research Projects |
Development of Anti-COVID RNAi Therapeutics Using Human iPSC-Derived Alveolar Epithelial Cells |
$150,000 |
| Celularity Inc. |
William van der Touw |
Clinical Trial Stage Projects |
A phase I/II study of human placental hematopoietic stem cell derived natural killer cells (CYNK-001) for the treatment of adults with COVID-19 |
$315,000 |
| University of California, San Francisco |
Dr. Michael Matthay MD |
Clinical Trial Stage Projects |
Mesenchymal Stromal Cells for ARDS (COVID positive and COVID negative) |
$699,798 |
| City of Hope, Beckman Research Institute |
Prof. John A. Zaia |
Clinical Trial Stage Projects |
Evaluation and Characterization of SARS-CoV-2 Antibody in Convalescent Volunteer Plasma Donors for Potential Therapeutic Use |
$999,999 |
| University of California, Los Angeles |
Dr. Vaithilingaraja Arumugaswami PhD |
Therapeutic Translational Research Projects |
COVID-19 Antiviral Therapy to Block Direct Cell Injury and Associated Tissue Damage |
$349,999 |
| Sanford Burnham Prebys Medical Discovery Institute |
Dr. Evan Y. Snyder |
Discovery Research Projects |
Using hiPSC-derived lung organoids, a clinically-relevant system, to validate & winnow a list of approved drugs that inhibit SARS-CoV-2 cytopathy |
$219,006 |
| University of California, Los Angeles |
Dr. Lili Yang |
Discovery Research Projects |
Battling COVID-19 Using Off-The-Shelf HSC-Engineered iNKT Cells |
$250,000 |
| University of Southern California |
Preet M Chaudhary |
Discovery Research Projects |
Chimeric Antigen Receptor Targeting Spike Glycoprotein of SARS-cov2 |
$248,125 |
| University of California, San Diego |
Dr Karen Christman |
Discovery Research Projects |
Pro-healing biomaterial for treating lung inflammation associated with COVID-19 |
$221,758 |
| City of Hope, Beckman Research Institute |
Dr Jianhua Yu |
Discovery Research Projects |
Persistent Off-the-Shelf meACE2-CAR-IL-15 NK Cells Derived from CD34(+) Cord Blood Stem Cells to Prevent and Treat COVID-19 |
$150,000 |